Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 572 results for "cadila pharmaceutical"

Three Made in India drugs recalled in US: FDA
Financial Express

Three Made in India drugs recalled in US: FDA

Three different drugs made in India, including by Cadila Pharma and Alkem Laboratories, are being recalled in the US for not meeting the manufacturing norms. According to the latest Enforcement Report of the USFDA, Cadila Pharmaceuticals Ltd is ... Business Standard, 3 days ago

18 images for cadila pharmaceutical

Financial Express, 3 days ago, 1 week ago
International Business Times India, 1 week ago
Money Control, 2 weeks ago
EuroInvestor, 2 months ago
Blic Online, 2 months ago
EuroInvestor, 2 months ago
Money Today, 2 months ago
Pharmaceutical Technology, 2 months ago
Silicon India, 2 months ago

Allergan settles with Zydus and Cadila over Delzicol: 4 things to know

d-based Allergan Pharmaceuticals settled litigation over its Delzicol prescription used to treat ulcerative colitis. Here's what you should know. 1. Allegan settled with Pennington, N.J.-based Zydus Pharmaceuticals and Ahmedabad, India-based ...
 Beckers ASC Review5 days ago Allergan Announces Settlement of a DELZICOL® mesalamine Patent Litigation  4 Traders2 days ago Zydus announces settlement of patent litigation  India Infoline1 week ago Allergan settles patent litigation with Zydus Pharma and Cadila regarding  TD Ameritrade1 week ago


Pharmaceutical major Zydus Cadila of Ahmedabad has settled a patent case with Allergan of US relating to Delzicol (mesalamine). However, the settlement is subject to approval from the US Food and Drug Administration (FDA). Zydus Pharmaceuticals ...
 Pharmacy Choice4 days ago Zydus Cadila settles patent litigation relating to Allergan's DELZICOL  HT Syndication6 days ago
India Infoline

Cadila Healthcare Ltd 28 Oct 2016

global pharmaceutical company Cadila Healthcare Ltd Q2FY17 Consolidated Results Q2FY17: (Rs. in crore) Q2FY17 YoY (%) Revenue 2,403.50 0.4 EDITDA 516 [15.5] EBITDA Margin (%) 21.5 [404] Net Profit 327.70 [16.2] ***EBITDA margin ...
 India Infoline1 month ago CADILA HEALTHCARE : corrects on profit booking  4 Traders1 week ago Cadila Healthcare corrects on profit booking  India Infoline1 week ago Takeda Pharmaceutical's (TKPHF) CEO Christophe Weber on Q2 2016 Results - Earnings Call Transcript  Seeking Alpha1 month ago

Sun Pharma, Cadila Healthcare recall products from US market

Zydus Pharmaceuticals USA is recalling 2,472 units of Bupropion Hydrochloride extended release tablets manufactured by Ahmedabad-based Cadila Healthcare New Delhi: The US-based subsidiaries of two domestic drug firms—Sun Pharma and Cadila ...
 Livemint.com1 week ago Sun will recall 31,762 bottles of anti-depressant  Smart Investor1 month ago

Pankaj Patel of Zydus Cadila to replace Neotia as FICCI President

Share Tweet Share Share Share Pankaj Patel, CMD of leading pharmaceutical company Zydus Cadila, has been elected President of the Federation of Indian Chambers of Commerce and Industry (FICCI) for 2017, replacing ...
 EHealth Magazine2 weeks ago FICCI announces Pankaj Patel as the new President  Topnews.in2 weeks ago Pankaj Patel becomes National PresidentElect of FICCI  DeshGujarat2 weeks ago Zydus Cadila's CMD Pankaj Patel elected the president of FICCI  India Infoline2 weeks ago

Pharma profits hit in US this quarter

Firms like Dr Reddy's and Cadila have seen US revenues dip due to heavy pressure on generics market The US market has been the cause of worry of some of the major pharmaceutical players this quarter, dragging their net profit and revenues. While ...
 Business Standard India1 month ago Nitika Pharma's 4th excipient plant to come up in Mihan  PharmaBiz2 weeks ago US drags pharma profits, revenues this quarter  Smart Investor1 month ago Pharma shares surge post Q2 results  Smart Investor1 month ago
International Business Times India

Vietnam blacklists 39 Indian drug firms

Giant drug makers like Aurobindo Pharma, Cadila and Mcleods Pharmaceuticals are among 39 Indian firms that have been blacklisted by Vietnam for quality standard violations. The country's regulators have also banned companies from Bangladesh and ...
 CPhI.cn1 week ago Vietnam bans 39 Indian drug firms  Economic Times2 weeks ago 39 Indian drug companies blacklisted by Vietnam  International Business Times India2 weeks ago
Pocket News

Gujarat based firm launches first indigenously developed seasonal influenza vaccine

Ahmedabad: Ahmedabad based CPL Biologicals Pvt. Ltd, a joint-venture biotechnology company of Cadila Pharmaceuticals Ltd, India and Novavax Inc., USA, has become the first Indian company to indigenously develop a vaccine for Seasonal Influenza, ...
 DeshGujarat3 weeks ago Cadila develops India's first virus like particle vaccine for treating flu  Smart Investor3 weeks ago Cadila Pharmaceuticals Develops India's First Virus Like Particle Vaccine For Treating Flu  Biotechin.Asia2 weeks ago CPL Biologicals launches Cadiflu-S - world's first VLP vaccine for seasonal influenza  PharmaBiz3 weeks ago

CPL Biologicals develops vaccine for seasonal influenza

CPL Biologicals, a joint-venture biotechnology company of Cadila Pharmaceuticals and US-based Novavax Inc, has indigenously developed a vaccine for seasonal influenza. The Ahmedabad-based company has launched 'Cadiflu-S', which is also the first ...
 Business Standard3 weeks ago CPL develops vaccine for seasonal influenza  Millennium Post3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less